ArticleOrphanet journal of rare diseases2026
Symptoms and correlates of depression and anxiety in children and adolescents with juvenile idiopathic arthritis.
Article in Orphanet journal of rare diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveJuvenile idiopathic arthritis (JIA) can impair physical functioning and increase psychological burden. This study aimed to examine factors associated with clinically relevant depression and anxiety symptoms, and to describe the prevalence of clinically relevant depression and anxiety symptoms in children and adolescents with JIA.
methodsWe conducted a prospective cross-sectional study from July 2020 to June 2022 among JIA patients aged 8‒17 years at the largest university-based tertiary hospital in Bangkok, Thailand. Clinically relevant depression and anxiety symptoms were measured using the Children’s Depression Inventory (CDI) and the Screen for Child Anxiety Related Disorders (SCARED).
resultsEighty-seven patients (50 males, 37 females) with a median age of 12.6 (IQR 9.8‒14.4) years were enrolled. The median disease duration was 38 (IQR 10‒67) months, and 61 (70.1%) exhibited clinically inactive disease. Nine (10.3%) had clinically relevant depressive symptoms, while 45 (51.7%) had clinically relevant anxiety symptoms. Among these 45, 34 (75.6%) exhibited separation anxiety, 16 (35.6%) social anxiety, 15 (33.3%) school anxiety, 6 (13.3%) panic symptoms, and 6 (13.3%) generalized anxiety. CDI scores were significantly correlated with SCARED scores (r = 0.519, P < 0.001). Multiple linear regression revealed that biologic therapy was associated with clinically relevant depressive symptoms (standard β = 0.353, 95%CI 3.064–13.286, P = 0.002), whereas disability was associated with clinically relevant anxiety symptoms (standard β = 0.325, 95%CI 0.998-10.153, P = 0.018).
conclusionsSymptoms of depression and anxiety were common even in JIA patients with clinically inactive disease. Routine mental health screening should be integrated into clinical care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.